Loading...
XJSE
GRT
Market cap3.46bUSD
Dec 05, Last price  
1,716.00ZAR
1D
-1.10%
1Q
22.22%
Jan 2017
-33.72%
Name

Growthpoint Properties Ltd

Chart & Performance

D1W1MN
XJSE:GRT chart
P/E
45.81
P/S
4.04
EPS
0.37
Div Yield, %
6.74%
Shrs. gr., 5y
2.88%
Rev. gr., 5y
4.50%
Revenues
14.40b
+4.81%
1,181,714,0001,380,172,0002,362,000,0002,920,000,0003,430,000,0004,206,000,0004,640,000,0005,290,000,0005,782,000,0006,605,000,0007,870,000,00010,219,000,00010,755,000,00010,926,000,00011,554,000,00012,361,000,00013,126,000,00013,048,000,00013,740,000,00014,401,000,000
Net income
1.27b
-46.14%
482,000603,0001,000,000-98,000,000-69,000,000106,000,000-235,000,000-921,000,000-1,006,000,0005,579,000,0006,955,000,0005,159,000,0007,524,000,0006,663,000,0006,321,000,000-6,865,000,000-497,000,0007,937,000,0002,356,000,0001,269,000,000
CFO
5.74b
-20.98%
16,450,0002,744,00099,000,000384,000,00093,000,000204,000,000-235,000,000-773,000,000-166,000,000-34,000,000-1,357,000,000652,000,000-603,000,0006,762,000,0006,458,000,0005,557,000,0004,876,000,0005,798,000,0007,258,000,0005,735,000,000
Dividend
Oct 16, 202458.3 ZAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Growthpoint is the largest South African primary JSE-listed REIT with a quality portfolio of 440 directly owned properties in South Africa (RSA) valued at R73.4bn, including four hospitals and one medical chambers valued at R2.6bn owned by Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint has a 61.8% shareholding in GHPH. We have a 62.2% interest in ASX-listed Growthpoint Properties Australia Limited (GOZ), which owns 58 properties in Australia valued at R51.8bn and a 52.1% interest in LSE-listed Capital & Regional Plc (C&R), which owns seven properties in the United Kingdom valued at R14.8bn.
IPO date
Jul 01, 1992
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT